Abstract
Hepatitis B virus (HBV) is a major factor in the development of primary liver cancer in many areas of the world (Beasley 1982). The mechanisms by which HBV causes cell transformation are not understood (see Schlicht and Schaller, this volume). Viral DNA is integrated into hepatocyte chromosomes early after infection, but the cellular sites of integration are varied, and no common sites have been observed in tumors thus far (Koshy 1987). Furthermore, there is no evidence of integration at a genetic locus known to be concerned with transformation or cell proliferation. A single exception to this is a recently reported case in which HBV DNA was inserted into host DNA sequences homologous to the cellular v-erb-A protooncogene and certain steroid hormone receptors (Dejean et al. 1986; deThe et al. 1987) and which has since been shown to encode a novel retinoic acid receptor (Brand et al. 1988; Benbrook et al. 1988). It is also known that the integration of HBV DNA promotes genetic instability by chromosome rearrangements including deletion of cellular DNA and translocations (Koch et al. 1984; Rogler et al. 1987). The significance of these findings is at present unclear. Thus, as a rule, there is little evidence to provide a basis for a common cis-acting virus function in tumorigenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology 2: 21–26
Benbrook D, Lernhardt D, Pfahl M (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature, 333: 669–672
Brand N, Petkovitch M, Krust A, Chambon P, deThe H, Marchio A, Tiollais P, Dejean A (1988) Identification of a second human retinoic acid receptor. Nature, 332: 850–853
Chang HK, Chou CK, Chang C, Su TS, Hu CP, Yoshida M, Ting LP (1987) The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter. Nucleic Acids Res, 15: 2261–2268
Cross SL, Feinberg M, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ (1987) Regulation of the human interleukin-2-receptor alpha chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-1. Cell, 49: 47–56
Dejean A, Bougueleret L, Grzeschik KH, Tiollais P (1986) Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature, 322: 70–72
deThe H, Marchio A, Tiollais P, Dejean A (1987) A novel steroid thyroid hormone receptor gene inappropriately expressed in human hepatocellular carcinoma. Nature, 330: 667–670
Freytag von Loringhoven A, Koch S, Hofschneider PH, Koshy R (1985) Co-transcribed 3’ host sequences augment expression of integrated hepatitis B virus DNA. EMBO J 4: 249–255
Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B virus. Ann Rev Bio-chem 56:651–693
Gorman C, Moffat L, Howard B (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 29: 1046–1051
Gough NM (1983) Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs. J Mol Biol, 165: 683–699
Koch S, Freytag von Loringhoven A, Kahmann R, Hof Schneider PH, Koshy R (1984) The genetic organisation of integrated hepatitis B virus DNA in the human hepatoma cell line PLC/PRF/5. Nucleic Acids Res 12: 6871–6886
Kodama K, Ogasawara N, Yoshikama H, Murakami S (1985) Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutionary relationship between hepadnaviruses. J Virol, 56:978–986
Koshy R (1987) Integrated hepatitis B virus genomes in human primary liver cancer: a consideration of molecular mechanisms of oncogenesis. In: Hofschneider PH, Munk K (eds) Viruses in human tumors. Contr Oncol, vol 24, pp 97–112
Miller RH, Robinson WS (1986) Common evolutionary origin of hepatitis B virus and retroviruses. Proc Nat Acad Sci USA, 83: 2531–2535
Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K (1987). The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes and Development, 1: 773–782
Rogler C, Hino O, Su C-Y (1987) Molecular aspects of persistent woodchuck hepatitis virus and hepatitis B virus infection and hepatocellular carcinoma. Hepatology, 7: 74s-78s
Roosinck MJ, Jameel S, Loukin SH, Siddiqui A (1986) Expression of hepatitis B viral core region in mammalian cells. Mol Cell Biol, 6: 1393–1400
Shaul Y, Rutter WJ, Laub O (1985) A human hepatitis B viral enhancer element. EMBO J 4: 427–430
Siddiqui A, Jameel S, Mapoles J (1987) Expression of hepatitis B virus X gene in mammalian cells. Proc Nat Acad Sci USA, 84: 2513–2517
Spandau FD, Lee C-H (1988) Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol, 62: 427–434
Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcriptase of an RNA intermediate. Cell, 29: 403–415
Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature, 317: 489–495
Tognoni A, Cattaneo R, Serfling E, Schaffner W (1985) A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res, 13: 7457–7472
Treinin M, Laub O (1987) Identification of a promoter element located upstream from the hepatitis B virus X gene. Mol Cell Biol, 7: 545–548
Twu JR-Shin, Lee C-H, Lin P-M, Schloemer RH (1988) Hepatitis B virus suppresses expression of human ß-interferon. Proc. Nat. Acad. Sci. USA, 85: 252–256
Wollersheim M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene, 3: 545–552
Yaginuma K, Shirakata Y, Kobayashi M, Koike K (1987) Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Nat Acad Sci USA, 84: 2678–2682
Zahm P, Hofschneider PH, Koshy R (1988) The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene, 3: 169–177
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Koshy, R., Hofschneider, P.H. (1989). Transactivation by Hepatitis B Virus May Contribute to Hepatocarcinogenesis. In: Knippers, R., Levine, A.J. (eds) Transforming Proteins of DNA Tumor Viruses. Current Topics in Microbiology and Immunology, vol 144. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74578-2_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-74578-2_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74580-5
Online ISBN: 978-3-642-74578-2
eBook Packages: Springer Book Archive